Clinical Trials Search Results
- ACCRU RU011201I
A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.
- Novartis CRAD001Y24135
An open-label, Phase II Single-Arm study of Everolimus in combination with Letrozole in the treatment of postmenopausal women with estrogen receptor positive Metastatic Breast Cancer